Literature DB >> 9795077

Evaluation of different partial AUCs as indirect measures of rate of drug absorption in comparative pharmacokinetic studies.

C Duquesnoy1, L F Lacey, O N Keene, A Bye.   

Abstract

The performance of different partial AUCs, including partial AUC from zero to t(max) of the reference formulation (AUC(r)) and partial AUC from zero to tmax of test or reference formulation, whichever occurs earliest (AUC(e), as indirect measures of rate of absorption have been evaluated using simulated experiments. The performance of these metrics relative to C(max), t(max) and C(max)/AUC(infinity) was further assessed using the results of actual studies involving a Glaxo drug. The normalised metrics AUC(r)/AUC(infinity) and AUC(e)/AUC(infinity) have also been evaluated. Our provisional conclusions were: (1) AUC(r)/AUC(infinity) and AUC(e)/AUC(infinity) had greater statistical power than C(max) and the non-normalised partial AUCs at detecting true differences in rate of absorption. Using real data, the performance of AUC(e)/AUC(infinity) was poor, however, the performance of AUC(r)/AUC(infinity) was good; (2) C(max)/AUC(infinity) was more precisely estimated than AUC(r)/AUC(infinity) or AUC(e)/AUC(infinity) and may be a superior metric for assessing absorption rates of highly variable drugs.

Mesh:

Substances:

Year:  1998        PMID: 9795077     DOI: 10.1016/s0928-0987(97)10023-9

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  3 in total

1.  MDR1 genotypes do not influence the absorption of a single oral dose of 600 mg valacyclovir in healthy Chinese Han ethnic males.

Authors:  Yan Zhang; Xue-Hua Jiang; Yu-Qin Hu; Zhi-Ru Li; Lan Su; Zhan-Guo Wang; Guo Ma
Journal:  Br J Clin Pharmacol       Date:  2008-05-06       Impact factor: 4.335

2.  Use of partial AUC (PAUC) to evaluate bioequivalence--a case study with complex absorption: methylphenidate.

Authors:  Jeanne Fourie Zirkelbach; Andre J Jackson; Yaning Wang; Donald J Schuirmann
Journal:  Pharm Res       Date:  2012-09-25       Impact factor: 4.200

3.  Method of variability optimization in pharmacokinetic data analysis.

Authors:  Tomasz Grabowski; Jerzy Jan Jaroszewski; Walerian Piotrowski; Małgorzta Sasinowska-Motyl
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-06-19       Impact factor: 2.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.